BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26196255)

  • 1. An Approach to More Accurate Model Systems for Purple Acid Phosphatases (PAPs).
    Bernhardt PV; Bosch S; Comba P; Gahan LR; Hanson GR; Mereacre V; Noble CJ; Powell AK; Schenk G; Wadepohl H
    Inorg Chem; 2015 Aug; 54(15):7249-63. PubMed ID: 26196255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic structure and spectro-structural correlations of Fe(III)Zn(II) biomimetics for purple acid phosphatases: relevance to DNA cleavage and cytotoxic activity.
    Peralta RA; Bortoluzzi AJ; de Souza B; Jovito R; Xavier FR; Couto RA; Casellato A; Nome F; Dick A; Gahan LR; Schenk G; Hanson GR; de Paula FC; Pereira-Maia EC; de P Machado S; Severino PC; Pich C; Bortolotto T; Terenzi H; Castellano EE; Neves A; Riley MJ
    Inorg Chem; 2010 Dec; 49(24):11421-38. PubMed ID: 21080710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsymmetrical Fe(III)Co(II) and Ga(III)Co(II) complexes as chemical hydrolases: biomimetic models for purple acid phosphatases (PAPs).
    Xavier FR; Neves A; Casellato A; Peralta RA; Bortoluzzi AJ; Szpoganicz B; Severino PC; Terenzi H; Tomkowicz Z; Ostrovsky S; Haase W; Ozarowski A; Krzystek J; Telser J; Schenk G; Gahan LR
    Inorg Chem; 2009 Aug; 48(16):7905-21. PubMed ID: 19603814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal-ion mutagenesis: conversion of a purple acid phosphatase from sweet potato to a neutral phosphatase with the formation of an unprecedented catalytically competent Mn(II)Mn(II) active site.
    Mitić N; Noble CJ; Gahan LR; Hanson GR; Schenk G
    J Am Chem Soc; 2009 Jun; 131(23):8173-9. PubMed ID: 19507905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic and catalytic characterization of a functional Fe(III)Fe(II) biomimetic for the active site of uteroferrin and protein cleavage.
    Smith SJ; Peralta RA; Jovito R; Horn A; Bortoluzzi AJ; Noble CJ; Hanson GR; Stranger R; Jayaratne V; Cavigliasso G; Gahan LR; Schenk G; Nascimento OR; Cavalett A; Bortolotto T; Razzera G; Terenzi H; Neves A; Riley MJ
    Inorg Chem; 2012 Feb; 51(4):2065-78. PubMed ID: 22289382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for nonbridged coordination of p-nitrophenyl phosphate to the dinuclear Fe(III)-M(II) center in bovine spleen purple acid phosphatase during enzymatic turnover.
    Merkx M; Pinkse MW; Averill BA
    Biochemistry; 1999 Aug; 38(31):9914-25. PubMed ID: 10433698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoride inhibition of bovine spleen purple acid phosphatase: characterization of a ternary enzyme-phosphate-fluoride complex as a model for the active enzyme-substrate-hydroxide complex.
    Pinkse MW; Merkx M; Averill BA
    Biochemistry; 1999 Aug; 38(31):9926-36. PubMed ID: 10433699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and reactivity studies of heterodinuclear complexes modeling active sites in purple acid phospatases.
    Jarenmark M; Haukka M; Demeshko S; Tuczek F; Zuppiroli L; Meyer F; Nordlander E
    Inorg Chem; 2011 May; 50(9):3866-87. PubMed ID: 21452875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fe(III)Zn(II) form of recombinant human purple acid phosphatase is not activated by proteolysis.
    Funhoff EG; Bollen M; Averill BA
    J Inorg Biochem; 2005 Feb; 99(2):521-9. PubMed ID: 15621285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate forms an unusual tripodal complex with the Fe-Mn center of sweet potato purple acid phosphatase.
    Schenk G; Gahan LR; Carrington LE; Mitic N; Valizadeh M; Hamilton SE; de Jersey J; Guddat LW
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):273-8. PubMed ID: 15625111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-coordination-sphere effects increase the catalytic efficiency of an extended model for Fe(III)M(II) purple acid phosphatases.
    de Souza B; Kreft GL; Bortolotto T; Terenzi H; Bortoluzzi AJ; Castellano EE; Peralta RA; Domingos JB; Neves A
    Inorg Chem; 2013 Apr; 52(7):3594-6. PubMed ID: 23496379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic pathway for an unsymmetrical N(5)O(2) heptadentate ligand and its heterodinuclear iron(III)zinc(II) complex: a biomimetic model for the purple acid phosphatases.
    Xavier FR; Bortoluzzi AJ; Neves A
    Chem Biodivers; 2012 Sep; 9(9):1794-805. PubMed ID: 22976970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and catalytic characterization of a heterovalent Mn(II)Mn(III) complex that mimics purple acid phosphatases.
    Smith SJ; Riley MJ; Noble CJ; Hanson GR; Stranger R; Jayaratne V; Cavigliasso G; Schenk G; Gahan LR
    Inorg Chem; 2009 Nov; 48(21):10036-48. PubMed ID: 19852517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric mono- and dinuclear Ga
    Bosch S; Comba P; Gahan LR; Schenk G
    J Inorg Biochem; 2016 Sep; 162():343-355. PubMed ID: 26874376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct observation of multiple protonation states in recombinant human purple acid phosphatase.
    Funhoff EG; de Jongh TE; Averill BA
    J Biol Inorg Chem; 2005 Aug; 10(5):550-63. PubMed ID: 16096803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic characterization of the active Fe(III)Fe(III) and Fe(III)Fe(II) forms of a purple acid phosphatase model system.
    Comba P; Gahan LR; Mereacre V; Hanson GR; Powell AK; Schenk G; Zajaczkowski-Fischer M
    Inorg Chem; 2012 Nov; 51(22):12195-209. PubMed ID: 23110717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of the tetranuclear iron(III) complex of a new asymmetric multidentate ligand. A structural model for purple acid phosphatases.
    Boudalis AK; Aston RE; Smith SJ; Mirams RE; Riley MJ; Schenk G; Blackman AG; Hanton LR; Gahan LR
    Dalton Trans; 2007 Nov; (44):5132-9. PubMed ID: 17985020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observation of redox-induced electron transfer and spin crossover for dinuclear cobalt and iron complexes with the 2,5-di-tert-butyl-3,6-dihydroxy-1,4-benzoquinonate bridging ligand.
    Min KS; Dipasquale AG; Rheingold AL; White HS; Miller JS
    J Am Chem Soc; 2009 May; 131(17):6229-36. PubMed ID: 19358538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate ester cleavage promoted by a tetrameric iron(III) complex.
    Kantacha A; Buchholz R; Smith SJ; Schenk G; Gahan LR
    J Biol Inorg Chem; 2011 Jan; 16(1):25-32. PubMed ID: 20798967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The highly exposed loop region in mammalian purple acid phosphatase controls the catalytic activity.
    Funhoff EG; Klaassen CH; Samyn B; Van Beeumen J; Averill BA
    Chembiochem; 2001 May; 2(5):355-63. PubMed ID: 11828464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.